IL-6 cooperates with G-CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation

Journal of Immunology

Volumn 190, Issue 11, 2013, Pages 5882-5893

  Yan, Bin ^a   Wei, Jing Jing ^a   Yuan, Ye ^a   Sun, Rui ^a   Li, Dong ^a   Luo, Jing ^a   Liao, Sheng Jun ^a   Zhou, Yuan Hong ^a   Shu, Yu ^a   Wang, Qi ^a   Zhang, Gui Mei ^a   Feng, Zuo Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ARTICLE; BONE MARROW; BV8 GENE; CONTROLLED STUDY; CYTOTOXICITY; DEGRANULATION; DOWN REGULATION; EXOCYTOSIS; GENE; GENE EXPRESSION; GROWTH INHIBITION; MACROPHAGE; MMP8 GENE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAB27A GENE; TRAIL GENE; TUMOR GROWTH; UPREGULATION;

ANIMALS; BONE MARROW; CELL LINE, TUMOR; GASTROINTESTINAL HORMONES; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE COLONY-STIMULATING FACTOR; INTERFERON-BETA; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASMS; NEUROPEPTIDES; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; RAB GTP-BINDING PROTEINS; STAT3 TRANSCRIPTION FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84878073042     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201881     Document Type: Article

References (53)

1. Gregory, A. D., and A. M. Houghton. 2011. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 71: 2411-2416.
2. Di Carlo, E., G. Forni, P. Lollini, M. P. Colombo, A. Modesti, and P. Musiani. 2001. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97: 339-345. (Pubitemid 32060315)
3. Tazzyman, S., C. E. Lewis, and C. Murdoch. 2009. Neutrophils: key mediators of tumour angiogenesis. Int. J. Exp. Pathol. 90: 222-231.
4. Houghton, A. M. 2010. The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle 9: 1732-1737.
5. Michael, M., D. Goldstein, S. J. Clarke, A. D. Milner, P. Beale, M. Friedlander, and P. Mitchell. 2006. Prognostic factors predictive of response and survival to a modified FOLFOX regimen: importance of an increased neutrophil count. Clin. Colorectal Cancer 6: 297-304. (Pubitemid 46157479)
6. Schmidt, H., S. Suciu, C. J. Punt, M. Gore, W. Kruit, P. Patel, D. Lienard, H. von der Maase, A. M. Eggermont, and U. Keilholz; American Joint Committee on Cancer Stage IV Melanoma; EORTC 18951. 2007. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. J. Clin. Oncol. 25: 1562-1569. (Pubitemid 46733083)
7. Kao, S. C., N. Pavlakis, R. Harvie, J. L. Vardy, M. J. Boyer, N. van Zandwijk, and S. J. Clarke. 2010. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin. Cancer Res. 16: 5805-5813.
8. Cho, H., H. W. Hur, S. W. Kim, S. H. Kim, J. H. Kim, Y. T. Kim, and K. Lee. 2009. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol. Immunother. 58: 15-23.
9. Koga, Y., A. Matsuzaki, A. Suminoe, H. Hattori, and T. Hara. 2004. Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils. Cancer Res. 64: 1037-1043. (Pubitemid 38176907)
10. Cantarella, G., N. Risuglia, R. Dell'eva, L. Lempereur, A. Albini, G. Pennisi, G. M. Scoto, D. N. Noonan, and R. Bernardini. 2006. TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells. Br. J. Cancer 94: 1428-1435. (Pubitemid 43772277)
11. + cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature. Blood 115: 2231-2240.
12. Güngör, N., R. W. Godschalk, D. M. Pachen, F. J. Van Schooten, and A. M. Knaapen. 2007. Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: role of myeloperoxidase. FASEB J. 21: 2359-2367. (Pubitemid 47230666)
13. Nozawa, H., C. Chiu, and D. Hanahan. 2006. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. USA 103: 12493-12498. (Pubitemid 44267286)
14. Jablonska, J., S. Leschner, K. Westphal, S. Lienenklaus, and S. Weiss. 2010. Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J. Clin. Invest. 120: 1151-1164.
15. Shojaei, F., X. Wu, X. Qu, M. Kowanetz, L. Yu, M. Tan, Y. G. Meng, and N. Ferrara. 2009. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc. Natl. Acad. Sci. USA 106: 6742-6747.
16. Shojaei, F., M. Singh, J. D. Thompson, and N. Ferrara. 2008. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc. Natl. Acad. Sci. USA 105: 2640-2645. (Pubitemid 351520566)
17. Theilgaard-Mönch, K., B. T. Porse, and N. Borregaard. 2006. Systems biology of neutrophil differentiation and immune response. Curr. Opin. Immunol. 18: 54-60. (Pubitemid 43049648)
18. Shojaei, F., X. Wu, C. Zhong, L. Yu, X. H. Liang, J. Yao, D. Blanchard, C. Bais, F. V. Peale, N. van Bruggen, et al. 2007. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450: 825-831. (Pubitemid 350231321)
19. Nakamae-Akahori, M., T. Kato, S. Masuda, E. Sakamoto, H. Kutsuna, F. Hato, Y. Nishizawa, M. Hino, and S. Kitagawa. 2006. Enhanced neutrophil motility by granulocyte colony-stimulating factor: the role of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. Immunology 119: 393-403. (Pubitemid 44571058)
20. Walker, F., H. H. Zhang, V. Matthews, J. Weinstock, E. C. Nice, M. Ernst, S. Rose-John, and A. W. Burgess. 2008. IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice. Blood 111: 3978-3985.
21. Okazaki, T., S. Ebihara, M. Asada, A. Kanda, H. Sasaki, and M. Yamaya. 2006. Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models. Int. Immunol. 18: 1-9. (Pubitemid 43057031)
22. Tsukamoto, T., Y. Kumamoto, N. Miyao, N. Masumori, A. Takahashi, and M. Yanase. 1992. Interleukin-6 in renal cell carcinoma. J. Urol. 148: 1778-1781, discussion 1781-1782.
23. Wu, C. W., S. R. Wang, M. F. Chao, T. C. Wu, W. Y. Lui, F. K. P'eng, and C. W. Chi. 1996. Serum interleukin-6 levels reflect disease status of gastric cancer. Am. J. Gastroenterol. 91: 1417-1422. (Pubitemid 26236381)
24. Zhang, G. J., and I. Adachi. 1999. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res. 19 (2B): 1427-1432. (Pubitemid 29257471)
25. Nakashima, J., M. Tachibana, Y. Horiguchi, M. Oya, T. Ohigashi, H. Asakura, and M. Murai. 2000. Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Clin. Cancer Res. 6: 2702-2706. (Pubitemid 30482107)
26. Duffy, S. A., J. M. Taylor, J. E. Terrell, M. Islam, Y. Li, K. E. Fowler, G. T. Wolf, and T. N. Teknos. 2008. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer 113: 750-757.
27. Geng, H., G. M. Zhang, D. Li, H. Zhang, Y. Yuan, H. G. Zhu, H. Xiao, L. F. Han, and Z. H. Feng. 2006. Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J. Immunol. 176: 1411-1420. (Pubitemid 43134283)
28. Li, W. C., K. L. Ralphs, and D. Tosh. 2010. Isolation and culture of adult mouse hepatocytes. Methods Mol. Biol. 633: 185-196.
29. Nick, J. A., S. K. Young, K. K. Brown, N. J. Avdi, P. G. Arndt, B. T. Suratt, M. S. Janes, P. M. Henson, and G. S. Worthen. 2000. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J. Immunol. 164: 2151-2159. (Pubitemid 30108774)
30. Weidner, N. 1995. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147: 9-19.
31. Bustin, S. A., V. Benes, J. A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M. W. Pfaffl, G. L. Shipley, et al. 2009. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55: 611-622.
32. Abdel-Latif, D., M. Steward, D. L. Macdonald, G. A. Francis, M. C. Dinauer, and P. Lacy. 2004. Rac2 is critical for neutrophil primary granule exocytosis. Blood 104: 832-839. (Pubitemid 38970582)
33. Peikert, T., J. D. Finkielman, A. M. Hummel, M. E. McKenney, G. Gregorini, M. Trimarchi, and U. Specks. 2008. Functional characterization of antineutrophil cytoplasmic antibodies in patients with cocaine-induced midline destructive lesions. Arthritis Rheum. 58: 1546-1551. (Pubitemid 351705946)
34. Gong, W., G. M. Zhang, Y. Liu, Z. Lei, D. Li, Y. Yuan, B. Huang, and Z. H. Feng. 2008. IFN-gamma withdrawal after immunotherapy potentiates B16 melanoma invasion and metastasis by intensifying tumor integrin alphavbeta3 signaling. Int. J. Cancer 123: 702-708. (Pubitemid 351898431)
35. Liu, Y., B. Huang, Y. Yuan, W. Gong, H. Xiao, D. Li, Z. R. Yu, F. H. Wu, G. M. Zhang, and Z. H. Feng. 2007. Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin. Int. J. Cancer 121: 184-192. (Pubitemid 46753867)
36. Ardi, V. C., T. A. Kupriyanova, E. I. Deryugina, and J. P. Quigley. 2007. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc. Natl. Acad. Sci. USA 104: 20262-20267.
37. Brzezinska, A. A., J. L. Johnson, D. B. Munafo, B. A. Ellis, and S. D. Catz. 2009. Signalling mechanisms for Toll-like receptor-activated neutrophil exocytosis: key roles for interleukin-1-receptor-associated kinase-4 and phosphatidylinositol 3-kinase but not Toll/IL-1 receptor (TIR) domain-containing adaptor inducing IFN-beta (TRIF). Immunology 127: 386-397.
38. Fukuzono, S., T. Kato, H. Fujita, N. Watanabe, and S. Kitagawa. 2010. Granulocyte colony-stimulating factor negatively regulates Toll-like receptor agonist-induced cytokine production in human neutrophils. Arch. Biochem. Biophys. 495: 144-151.
39. Bluyssen, H. A., M. M. Rastmanesh, C. Tilburgs, K. Jie, S. Wesseling, M. J. Goumans, P. Boer, J. A. Joles, and B. Braam. 2010. IFN gamma-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells. Am. J. Physiol. Cell Physiol. 299: C354-C362.
40. Johnson, J. L., A. A. Brzezinska, T. Tolmachova, D. B. Munafo, B. A. Ellis, M. C. Seabra, H. Hong, and S. D. Catz. 2010. Rab27a and Rab27b regulate neutrophil azurophilic granule exocytosis and NADPH oxidase activity by independent mechanisms. Traffic 11: 533-547.
41. Yang, J., and G. R. Stark. 2008. Roles of unphosphorylated STATs in signaling. Cell Res. 18: 443-451. (Pubitemid 351498851)
42. Wang, J., Q. Lin, H. Langston, and M. D. Cooper. 1995. Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunity 3: 475-484.
43. Bausch, D., T. Pausch, T. Krauss, U. T. Hopt, C. Fernandez-del-Castillo, A. L. Warshaw, S. P. Thayer, and T. Keck. 2011. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma. Angiogenesis 14: 235-243.
44. Aarbiou, J., M. Ertmann, S. van Wetering, P. van Noort, D. Rook, K. F. Rabe, S. V. Litvinov, J. H. van Krieken, W. I. de Boer, and P. S. Hiemstra. 2002. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J. Leukoc. Biol. 72: 167-174.
45. Simons, M. P., K. G. Leidal, W. M. Nauseef, and T. S. Griffith. 2008. TNF-related apoptosis-inducing ligand (TRAIL) is expressed throughout myeloid development, resulting in a broad distribution among neutrophil granules. J. Leukoc. Biol. 83: 621-629. (Pubitemid 351966872)
46. Croker, B. A., D. Metcalf, L. Robb, W. Wei, S. Mifsud, L. DiRago, L. A. Cluse, K. D. Sutherland, L. Hartley, E. Williams, et al. 2004. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20: 153-165. (Pubitemid 38258392)
47. Murray, P. J. 2007. The JAK-STAT signaling pathway: input and output integration. J. Immunol. 178: 2623-2629. (Pubitemid 46333135)
48. + cells to induce apoptosis of activated T cells. J. Immunol. 185: 2773-2782.
49. Rolph, M. S., A. Zaid, N. E. Rulli, and S. Mahalingam. 2011. Downregulation of interferon-β in antibody-dependent enhancement of dengue viral infections of human macrophages is dependent on interleukin-6. J. Infect. Dis. 204: 489-491.
50. Kortylewski, M., M. Kujawski, T. Wang, S. Wei, S. Zhang, S. Pilon-Thomas, G. Niu, H. Kay, J. Mulé, W. G. Kerr, et al. 2005. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat. Med. 11: 1314-1321. (Pubitemid 41752912)
51. Ivanov, V. N., A. Bhoumik, M. Krasilnikov, R. Raz, L. B. Owen-Schaub, D. Levy, C. M. Horvath, and Z. Ronai. 2001. Cooperation between STAT3 and c-jun suppresses Fas transcription. Mol. Cell 7: 517-528. (Pubitemid 32706344)
52. Hankey, P. A. 2009. Regulation of hematopoietic cell development and function by Stat3. Front. Biosci. 14: 5273-5290.
53. Ivanov, V. N., M. Krasilnikov, and Z. Ronai. 2002. Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling. J. Biol. Chem. 277: 4932-4944. (Pubitemid 34968531)